Authors: BONTKES HJ VANDUIN M DEGRUUL TD DUGGANKEEN MF WALBOOMERS JMM STUKART MJ VERHEIJEN RHM HELMERHORST TJM MEIJER CJLM SCHEPER RJ STEVENS FRA DYER PA SINNOTT P STERN PL

Citation: Hj. Bontkes et al., HPV-16 INFECTION AND PROGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA - ANALYSIS OF HLA POLYMORPHISM AND HPV-16 E6 SEQUENCE VARIANTS, International journal of cancer, 78(2), 1998, pp. 166-171

Authors: DEGRUIJL TD BONTKES HJ WALBOOMERS JMM STUKART MJ DOEKHIE FS REMMINK AJ HELMERHORST TJM VERHEIJEN RHM DUGGANKEEN MF STERN PL MEIJER CJLM SCHEPER RJ

Citation: Td. Degruijl et al., DIFFERENTIAL T-HELPER CELL RESPONSES TO HUMAN-PAPILLOMAVIRUS TYPE-16 E7 RELATED TO VIRAL CLEARANCE OR PERSISTENCE IN PATIENTS WITH CERVICALNEOPLASIA - A LONGITUDINAL-STUDY, Cancer research, 58(8), 1998, pp. 1700-1706

Authors: DUGGANKEEN MF KEATING PJ STEVENS FRA SINNOTT P SNIJDERS PJF WALBOOMERS JMM DAVIDSON S HUNTER RD DYER PA STERN PL

Citation: Mf. Duggankeen et al., IMMUNOGENETIC FACTORS IN HPV-ASSOCIATED CERVICAL-CANCER - INFLUENCE ON DISEASE PROGRESSION, European journal of immunogenetics, 23(4), 1996, pp. 275-284

Authors: ELLIS JRM KEATING PJ BAIRD J HOUNSELL EF RENOUF DV ROWE M HOPKINS D DUGGANKEEN MF BARTHOLOMEW JS YOUNG LS STERN PL

Citation: Jrm. Ellis et al., THE ASSOCIATION OF AN HPV16 ONCOGENE VARIANT WITH HLA-B7 HAS IMPLICATIONS FOR VACCINE DESIGN IN CERVICAL-CANCER, Nature medicine, 1(5), 1995, pp. 464-470